Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

cap

Bio-Rad Buys Ciphergen’s Proteomics Technology

PROTEOMICS IS EXPECTED TO BE ONE of the most active areas in molecular diagnostics and Bio-Rad Laboratories, Inc. has just staked a major claim to a promising proteomic technology. In a transaction announced on August 18, 2006, Bio-Rad will acquire the proprietary proteomics instrum…

Read More



Siemens’ IVD Purchases Are a Major Investment

CEO SUMMARY: In the space of just nine weeks, Siemens AG purchased Diagnostic Products Corp. (DPC) and Bayer Diagnostics. Siemens paid $1.86 billion and $5.31 billion, respectively, for the two invitro diagnostics (IVD) companies. Once it closes the acquisition of Bayer Diagnostics, Sieme…

Read More



IVD Executive Discusses Three Developing Trends

CEO SUMMARY: In a refreshingly candid assessment of current technology published in IVD Technology magazine, one lab industry executive describes both the successes and the failings of analyzers, automation, and software. He offers three trends he expects will address the deficiencies of …

Read More



Pathologist-Entrepreneurs Offer New Lab Automation

CEO SUMMARY: Since October 2003, the core laboratory of Detroit Medical Center University Laboratories has operated with a home-grown total laboratory automation (TLA) system. The 100-foot automated line currently connects to 11 instruments and the hardware cost only $200,000 to build and…

Read More



August 14, 2006 “Intelligence: Late Breaking Lab News”

Here’s some useful information for pathologists and practice administrators trying to gauge the interest that urologists, gastroenterologists, and dermatologists have in capturing the anatomic pathology revenues generated by their patient referrals (the TC/PC trend). Pathology Service Assoc…

Read More



Six Ex-IMPATH Officials Receive Their Sentences

CEO SUMMARY: Justice has been meted out to six individuals accused of criminal fraud in the Impath,Inc. case. During June, sentences were pronounced for former President and COO Richard P. Adelson and several other defendants. Adelson will serve 42 months in prison, pay a $1.2 million fin…

Read More



Defense Attorneys Discuss Details Of UroCor Jury Trial

CEO SUMMARY: This was the first criminal case involving anti-kickback violations brought against executives of a public laboratory company. Federal prosecutors charged the defendants with offering inducements to referring physicians in several ways. Defense counsel rebutted the prosecutio…

Read More



Pathology Clients Now Competing Against Pathologists

THIS ENTIRE ISSUE IS DEVOTED TO A SINGLE TOPIC: the exploding interest by specialist physicians in establishing their own in-practice ancillary service in anatomic pathology (AP). Once again, THE DARK REPORT is first to provide the pathology profession with a concise and insightful assessment of a di…

Read More



Office-Based Docs Want Anatomic Path Revenues

CEO SUMMARY: Specialist physicians think they’ve found gold in anatomic pathology services. Indifferent regions of the United States, urologists and gastroenterologists are taking active steps to cut themselves a piece from the anatomic pathology revenue pie. Some physician groups are b…

Read More



Labs Taught Physicians How to Do TC/PC Deals

CEO SUMMARY: As many pathology groups discover that their best urology and gastroenterology clients are taking serious steps to do their own anatomic pathology, they ask a basic question: How did their best-referring…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;